Prices delayed by at least 15 minutes | Print


Global Medical REIT (GMRE)

Common Stock
Sell: $8.03|Buy: $8.19|Change: 0.18 (-2.17%)

Open 

$8.21


Previous close 

$8.29


Trade high 

$8.235


Volume 

460,399


Year high 

$11.59


Year low 

$7.98


Dividend yield 

10.13%


Market capitalisation 

$531.91 mn


P/E ratio 

36.04


ISIN 

US37954A2042


This share can be held in a Dealing accountISALifetime ISAJISASIPP

Share price

Dividends

PreviousLatest
Record date27/12/202322/03/2024
Ex-dividend date26/12/202321/03/2024
Payment date09/01/202409/04/2024
Amount$0.21$0.21

Performance 30/04/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Global Medical REIT- 2.17
More...

Company profile

Global Medical REIT Inc is a Maryland corporation engaged predominantly in the acquisition of purpose-built healthcare facilities and the leasing of those facilities to physician groups and regional and national healthcare systems. The company's principal business objective is to provide attractive, risk-adjusted returns to its stockholders through a combination of reliable dividends and long-term capital appreciation. Its healthcare facilities are located in secondary markets and suburbs of primary markets and are typically leased to single-tenants under triple-net leases.

Sector 

Real Estate


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.